World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 22 August 2016
Main ID:  NCT01352052
Date of registration: 04/05/2011
Prospective Registration: No
Primary sponsor: Frederiksberg University Hospital
Public title: Interdisciplinary Rehabilitation of Patients With Chronic Widespread Pain IMPROvE
Scientific title: Interdisciplinary Rehabilitation and Evaluation Programme for Patients With Chronic Widespread Pain: Randomized Controlled Trial, the IMPROvE Study
Date of first enrolment: May 2011
Target sample size: 192
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT01352052
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment  
Phase:  N/A
Countries of recruitment
Denmark
Contacts
Name:     Kirstine Amris, MD
Address: 
Telephone:
Email:
Affiliation:  The Parker Institute, Frederiksberg University Hospital
Name:     Bente Danneskiold-Samsøe, Professor
Address: 
Telephone:
Email:
Affiliation:  The Parker Institute, Frederiksberg University Hospital
Key inclusion & exclusion criteria

Inclusion Criteria:

- age above 18

- fulfills the American College of Rheumatology (ACR) 1990 classification criteria of
widespread musculoskeletal pain i.e. reporting of pain axially and in all 4 body
quadrants for a minimum duration of 3 months

- willing to participate in a 2-week group-based rehabilitation programme

Exclusion Criteria:

- severe physical impairment necessitating assistance in personal activities of daily
living

- concurrent history of major psychiatric disorder not related to the pain disorder

- other medical conditions capable of causing patients symptoms (e.g. uncontrolled
inflammatory/autoimmune disorder, uncontrolled endocrine disorder, malignancy)

- not Danish speaking

- enrollment in any other clinical trial within the last 30 days



Age minimum: 18 Years
Age maximum: N/A
Gender: Female
Health Condition(s) or Problem(s) studied
Fibromyalgia
Chronic Widespread Pain
Intervention(s)
Other: interdisciplinary rehabilitation
Primary Outcome(s)
Assessment of Motor and Process Skills (AMPS) [Time Frame: change from baseline at the end of intervention and 6 months follow-up]
SF-36 Mental Composite Score [Time Frame: change from baseline at the end of intervention and 6 months follow-up]
Secondary Outcome(s)
Health related quality of life scales; Short-Form-36 Health Survey (SF-36) [Time Frame: change from baseline at the end of intervention and 6 months follow-up]
Depression; Major Depression Inventory (MDI) [Time Frame: change from baseline at the end of intervention and 6 months follow-up]
Pain catastrophizing; Coping Strategy Questionnaire (CSQ) [Time Frame: change from baseline at the end of intervention and at 6 months follow-up]
Pain self-efficacy; Pain Self-Efficacy Questionnaire [Time Frame: change from baseline at the end of treatment and at 6 months follow-up]
Anxiety; Generalised Anxiety Disorder (GAD-10) [Time Frame: change from baseline at the end of intervention and 6 months follow-up]
Cognitive functioning; ISPOCD 2 test battery [Time Frame: change from baseline at the end of intervention and 6 months follow-up]
Disease severity scales;Fibromyalgia Impact Questionnaire (FIQ) [Time Frame: change from baseline at the end of intervention and 6 months follow-up]
Activity intolerance; The Measure of Functional Ability (Tiredness) [Time Frame: change from baseline at the end of intervention and 6 months follow-up]
Secondary ID(s)
BDS-2011-099
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Oak Foundation
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history